32 Dulaglutide in the REWIND study and exenatide in the DURATION study improved both BP and lipid profiles in patients with T2D
Notably, DPP-IV targets include cytokines, growth factors, and neurotransmitters, in addition to islet-derived peptide hormones, indicating that the improvements in beta-cell function in response to DPP-IV inhibition may also be mediated by other intra-islet paracrine signaling factors
Bishop-Gilyard C, Berkowitz RI, Wadden TA, Gehrman CA, Cronquist JL
Improves physical performance
GLPro GLPatch occupies a legitimate and scientifically grounded niche in the botanical metabolic wellness category
The quest for a glowing complexion has led many to try countless productssome successful, some not so much